ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Emerging data with immunotherapy in ESCC and potential impact for clinical practice"
Episode Synopsis
touchTALKS for touchONCOLOLOGY
Listen to a leading expert discussing the recent developments in esophageal cancer with a primary focus on esophageal squamous cell carcinoma (ESCC)
The expert:
Dr Elizabeth Smyth, Addenbrooke’s Hospital, Cambridge, UK
Overview:
Part 1: Insights from 2021 (0:00)
Part 2: Insights from ASCO and ESMO GI 2022 (13:29)
Part 3: Insights from the updated ESMO Clinical Practice Guideline (24:08)
Part 4: Insights from ESMO Asia 2022 and ASCO GI 2023 (34:53)
This touchPODCAST is for HCPs only.
Funding for this touchPODCAST is from an independent medical education grant from Novartis. This activity is provided by touchIME.
For further information please visit: https://touchoncologyime.org/congress-renal-cell-carcinoma-asco-gu-2023
Listen to a leading expert discussing the recent developments in esophageal cancer with a primary focus on esophageal squamous cell carcinoma (ESCC)
The expert:
Dr Elizabeth Smyth, Addenbrooke’s Hospital, Cambridge, UK
Overview:
Part 1: Insights from 2021 (0:00)
Part 2: Insights from ASCO and ESMO GI 2022 (13:29)
Part 3: Insights from the updated ESMO Clinical Practice Guideline (24:08)
Part 4: Insights from ESMO Asia 2022 and ASCO GI 2023 (34:53)
This touchPODCAST is for HCPs only.
Funding for this touchPODCAST is from an independent medical education grant from Novartis. This activity is provided by touchIME.
For further information please visit: https://touchoncologyime.org/congress-renal-cell-carcinoma-asco-gu-2023
In God we trust